# LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient \(API\), Resveratrol: the COLO-PREVENT study

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [University of Leicester](/buyers/university-of-leicester/contract-awards)
- Tender value: £1,057,433
- Published: 31 March 2021
- Planned start: 1 June 2021
- Planned end: 31 May 2031
- Stage: open_tender
- Procurement category: services
- Notice ID: 863e46f4-bd31-4d8e-b7c4-9d793deb91b4-425254
- OCID: ocds-b5fd17-15d1767d-55cb-4107-90a6-2521ea688624

## Description

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient \(API\), Resveratrol: the COLO-PREVENT study

## Related contract awards

- [LUV01306 - DECIDE-TAD digital DST](/contracts/ocds-b5fd17-4d6858b0-9ded-44c9-9ae6-71969db29de6): University of Leicester
- [LUV01297 Framework agreement for the provision of next generation and third generation sequencing and sanger sequencing services](/contracts/ocds-b5fd17-bdfb99ad-ffee-4d3d-9c18-d322633afe52): University of Leicester
- [LUV01348 The supply and installation of a laser welder system](/contracts/ocds-b5fd17-b21f1ac7-3490-481d-a63e-026011a045f9): University of Leicester

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/863e46f4-bd31-4d8e-b7c4-9d793deb91b4-425254)